HOYA Corporation (HOCPF)
OTCMKTS · Delayed Price · Currency is USD
135.96
-4.36 (-3.11%)
Sep 11, 2025, 3:46 PM EDT
HOYA Corporation Market Cap
HOYA Corporation has a market cap or net worth of $49.08 billion as of September 12, 2025. Its market cap has increased by 4.69% in one year.
Market Cap
49.08B
Enterprise Value
45.71B
Revenue
6.07B
Ranking
n/a
PE Ratio
34.24
Stock Price
$135.96
Market Cap Chart
Since August 24, 1993, HOYA Corporation's market cap has increased from 2.05B to 49.08B, an increase of 2,295.67%. That is a compound annual growth rate of 10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 49.08B | 12.20% |
| Dec 30, 2024 | 43.74B | -0.19% |
| Dec 29, 2023 | 43.83B | 27.64% |
| Dec 30, 2022 | 34.34B | -37.37% |
| Dec 30, 2021 | 54.82B | 6.33% |
| Dec 30, 2020 | 51.56B | 42.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |